The B3GLCT gene helps cells add a small sugar tag to certain proteins so they fold and travel correctly. This gene plays an important role in early development, especially in the eyes. When both copies of the B3GLCT gene do not work properly, it causes Peters plus syndrome, which usually includes changes at the front of the eye and may also involve short stature, cleft lip or palate, and developmental differences.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or regulating activities in the body. Some genes hold the information needed to produce proteins, which are the parts of cells that do much of the work. Other genes are used mainly to control when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To look into this topic more closely, you can find more in the LearnHub.
Overview
B3GLCTGene function
What if the gene works
The B3GLCT gene helps add a sugar tag to certain proteins. This supports proper folding and release from cells, especially during early development.
Risk
What if the gene does not work
More severe variants in the B3GLCT gene can cause Peters plus syndrome, usually with eye changes from birth, especially corneal clouding. Some people also have short stature, developmental delay, and hand, foot, or facial differences, with severity varying by variant.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the B3GLCT gene, no B3GLCT-specific treatment or management approach is currently established. Care is based on the person's symptoms and routine specialist management.
Conditions associated with B3GLCT
Gene function
What if the gene works
Inside many cells, the B3GLCT gene helps place small sugar tags on newly made proteins. These tags help certain proteins fold, pass quality checks, and move to the right place. Understanding what the B3GLCT gene does in the body makes it easier to see how cells prepare proteins for normal tissue growth and upkeep.
The B3GLCT gene adds a small sugar called glucose to selected parts of certain newly made proteins. It works on short protein sections called thrombospondin repeats, which appear in many proteins used outside the cell.
This added sugar helps some proteins fold into their usual shape and pass the cell's built-in quality checks. It supports their movement through the endoplasmic reticulum (the cell's protein workshop) and along the normal shipping route.
Many proteins handled by this gene are later released from the cell or placed at the cell surface. By helping finish these proteins, this gene supports tissue structure and cell-to-cell signaling.
What is a variant?
Genetic variants are small differences in the DNA sequence of a gene. They are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the B3GLCT gene often lower or abolish the activity of an enzyme that adds a sugar tag needed for certain proteins to fold and move through the cell. This is how B3GLCT gene variants affect protein function: the enzyme may be unstable, cut short, or unable to bind its targets. In Peters plus syndrome, severe variants usually leave little or no activity, while milder variants may keep activity and can shape how early and how strongly features appear.
How variants are linked to conditions
Pathogenic variants in both copies of the B3GLCT gene cause Peters plus syndrome, a rare inherited condition. B3GLCT gene variants linked to Peters plus syndrome are associated with eye changes present from birth, often involving the front of the eye, along with short stature and varying developmental or learning difficulties. Some people also have cleft lip or palate or other body differences. Finding disease-causing variants in both gene copies can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a normal part of being human and are widespread in the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For B3GLCT, risk is mainly changed by inheritance rather than lifestyle. A child is affected when both parents pass on a nonworking copy of the B3GLCT gene, so family history and whether both parents are carriers are the key factors. There is not enough evidence to say that diet, exercise, or other everyday habits change this genetic risk.
Inheritance of B3GLCT variants
B3GLCT-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one B3GLCT gene variant from each parent, and parents who each carry one variant are typically unaffected themselves. When both parents are carriers, each pregnancy has a 25% chance of the child inheriting both variants, which helps explain how B3GLCT variants are inherited in families. Sons and daughters are affected at the same rate.
What does my B3GLCT result mean for my family?
Changes in the B3GLCT gene are linked to a rare condition called Peters plus syndrome, which is usually passed down in a recessive pattern. For family members, this often means parents can be healthy carriers, and brothers or sisters may also be carriers or, more rarely, be affected. Close relatives may want to learn whether the same gene change runs in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the B3GLCT gene, doctors use B3GLCT genetic testing on a blood sample or saliva sample. The lab reads the gene's DNA code to look for changes, and results can show whether a variant linked with Peters plus syndrome is present, absent, or uncertain.
When should I consider getting a genetic test?
Genetic testing for the B3GLCT gene may be considered when a baby or child has signs linked to Peters plus syndrome, especially serious eye changes present at birth along with growth, facial, or developmental differences. It can help if this condition runs in the family or after an affected pregnancy or child, to understand the chance of it happening again.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals varies with the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how the body absorbs, breaks down, or reacts to a drug, so the same treatment may work better for one person and less well for another. This is a common part of normal human variation and can influence both how well a medicine helps and how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation can affect a person’s response to medications. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the B3GLCT gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects they may cause. If you have questions about symptoms, a condition linked to this gene, or how a medicine is affecting you, talk with your doctor or pharmacist.
History
B3GLCT entered medical genetics through work on Peters plus syndrome, a rare inherited condition affecting the eyes and growth. In 2006, researchers linked harmful variants in the B3GLCT gene, then called B3GALTL, to this condition and gave families a clearer genetic explanation. From these first observations, research expanded steadily, showing that earlier reports based only on visible features had missed the underlying inherited cause. As laboratory methods improved, scientists also refined the gene’s name to better match what it does, leading to the current name B3GLCT. This history is mainly important within rare disease genetics, where it helped connect a distinctive pattern of clinical features to one specific gene.